OtherGastrointestinal, Hepatic, Pulmonary, and Renal
Long-term treatment of bile duct ligated rats with (sirolimus) rapamycin significantly attenuates liver fibrosis: Analysis of the underlying mechanisms
Erwin Biecker, Andrea De Gottardi, Markus Neef, Matthias Unternahrer, Vreni Schneider, Monika Ledermann, Hans Sagesser, Sidney Shaw and Jurg Reichen
Journal of Pharmacology and Experimental Therapeutics March 15, 2005, DOI: https://doi.org/10.1124/jpet.104.079616
Erwin Biecker
Andrea De Gottardi
Markus Neef
Matthias Unternahrer
Vreni Schneider
Monika Ledermann
Hans Sagesser
Sidney Shaw

This is a PDF-only article. The first page of the PDF of this article appears below.

In this issue
OtherGastrointestinal, Hepatic, Pulmonary, and Renal
Long-term treatment of bile duct ligated rats with (sirolimus) rapamycin significantly attenuates liver fibrosis: Analysis of the underlying mechanisms
Erwin Biecker, Andrea De Gottardi, Markus Neef, Matthias Unternahrer, Vreni Schneider, Monika Ledermann, Hans Sagesser, Sidney Shaw and Jurg Reichen
Journal of Pharmacology and Experimental Therapeutics March 15, 2005, DOI: https://doi.org/10.1124/jpet.104.079616
OtherGastrointestinal, Hepatic, Pulmonary, and Renal
Long-term treatment of bile duct ligated rats with (sirolimus) rapamycin significantly attenuates liver fibrosis: Analysis of the underlying mechanisms
Erwin Biecker, Andrea De Gottardi, Markus Neef, Matthias Unternahrer, Vreni Schneider, Monika Ledermann, Hans Sagesser, Sidney Shaw and Jurg Reichen
Journal of Pharmacology and Experimental Therapeutics March 15, 2005, DOI: https://doi.org/10.1124/jpet.104.079616